Status:
COMPLETED
Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?
Lead Sponsor:
Atheline Major-Pedersen
Collaborating Sponsors:
Novartis
Bayer
Conditions:
Insulin Resistance
Impaired Fasting Glucose
Eligibility:
All Genders
25-75 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether attenuation/normalization of elevated blood sugar after meals ameliorates vessel wall (endothelial) function in individuals with insulin resistance.
Detailed Description
Background:Insulin Resistance (IR) is accompanied by a high incidence and prevalence of cardiovascular disease. IR is present in individuals with pre-diabetes/ type 2 diabetes. Epidemiological data de...
Eligibility Criteria
Inclusion
- Insulin resistance, impaired glucose tolerance
Exclusion
- unstable chronic disease, acute disease
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00259168
Start Date
June 1 2003
End Date
March 1 2006
Last Update
December 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endothelial laboratory, Cardiology clinic Y-research, H:S Bispebjerg Hospital
Bispebjerg Bakke, Copenhagen, Copenhagen NV, Denmark, 2400